|
|
Volumn 224, Issue 3, 2012, Pages 193-194
|
|
Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: Death due to ventricular dysfunction
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 7;
FRESH FROZEN PLASMA;
RECOMBINANT PROTEIN;
VITAMIN K GROUP;
ACUTE KIDNEY FAILURE;
BLOOD CLOTTING TIME;
CASE REPORT;
CAUSE OF DEATH;
CRYOPRECIPITATE;
DISEASE SEVERITY;
ERYTHROCYTE CONCENTRATE;
EXTRACORPOREAL OXYGENATION;
GREAT VESSELS TRANSPOSITION;
HEART LEFT VENTRICLE FAILURE;
HEART OUTPUT;
HEART SURGERY;
HUMAN;
MEDIASTINUM DISEASE;
NEWBORN;
NEWBORN ASSESSMENT;
NEWBORN DEATH;
OPERATION DURATION;
POSTOPERATIVE HEMORRHAGE;
SHORT SURVEY;
TREATMENT FAILURE;
ACUTE KIDNEY INJURY;
CARDIOPULMONARY BYPASS;
CAUSE OF DEATH;
CHEST TUBES;
COMBINED MODALITY THERAPY;
EXTRACORPOREAL MEMBRANE OXYGENATION;
FACTOR VIIA;
FATAL OUTCOME;
HEART VENTRICLES;
HUMANS;
INFANT, NEWBORN;
ISCHEMIA;
MULTIPLE ORGAN FAILURE;
NECROSIS;
OFF-LABEL USE;
POSTOPERATIVE COMPLICATIONS;
POSTOPERATIVE HEMORRHAGE;
RECOMBINANT PROTEINS;
TRANSPOSITION OF GREAT VESSELS;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 84860586153
PISSN: 03008630
EISSN: 14393824
Source Type: Journal
DOI: 10.1055/s-0032-1308984 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
